Crossmark

Comparative efficacy and safety of denosumab biosimilar and originator in postmenopausal osteoporosis: a meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00393-025-01737-6

Published Online: 2025-09-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Young Ho https://orcid.org/0000-0003-4213-1909
Song, Gwan Gyu
License Information

Text and Data Mining valid from 2025-09-24

Version of Record valid from 2025-09-24
More Information

Article History

Received: 24 August 2025

Accepted: 17 September 2025

First Online: 24 September 2025

Declarations

:

: Y.H. Lee and G.G. Song declare that they have no competing interests.

: An ethics statement is not applicable because this study is based exclusively on published literature.

Document is current

Any future updates will be listed below